Human antibodies that recognize the epithelial glycoprotein antigen (EGP-2) are disclosed. The antibodies have a human light chain variable region and a human heavy chain variable region. Fragments of the antibodies and pharmaceutical compositions comprising the antibodies and their in vitro and in vivo applications in diagnosis and immunotherapy are also disclosed.
